The agreement in between Novo Nordisk and Swiss Ypsomed authorized in 2014 reveals lasting industrial prepare for the checked medication cagrisema.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/media-novo-nordisk-selects-supplier-to-produce-injection-pen-for-new-obesity-drug/